Approximately 530 Alabama independent drug store owners are seeking relief of as much as $5,000 per store per year in business license fees by excluding prescription sales from gross receipts, according to a report published Friday by the Alabama Media Group. State legislation has been introduced to that end, but is opposed by local municipalities looking at stark revenue reductions. "Cities like Montgomery and Mobile claim the hit would be excessive," the report noted. "In Mobile, city officials estimate that computing a store's gross sales by including prescription medicine has brought in an average of $465,000 annually for the past five years." (AL.com)
DIRs are as much about patient access as it is about pharmacy business issues.
The pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers.
Benzer Pharmacy’s program will focus on medication therapy management, chronic disease state management, asthma education and business development.
The operator of 10 pharmacies will offer in-store specials for a 10-week period.
Based on early data, the Centers for Disease Control and Prevention last week reported that flu vaccines this season are reducing a vaccinated person’s risk of getting sick and having to go to the doctor because of flu by about half (48%).
An analysis from Decision Resources Group examines the potential fallout for retail clinics from changes to the Affordable Care Act and Medicare funding.
Northwestern Ohio’s The Courier is reporting that CVS Health president and CEO Larry Merlo delivered a speech at Ohio Northern University titled “Driving More Affordable, Accessible and Effective Care,” in which he noted the ways pharmacy can help drive down healthcare costs. He said that retail pharmacy will play a key role in combatting such issues as medication non-adherence and stepping into primary care. “Retail pharmacy is oftentimes the front door to health care,” he reportedly said. “It provides more opportunities to interact with patients than any other site of care.” (The Courier)
The oral solution is a generic of Endo Pharmaceuticals’s Hycodan Oral Solution, 5 mg/1.5 mg per 5 ml.